Oluwatoyin Areo

Advisor, Bioassay Development Eli Lilly & Co.

Seminars

Monday 3rd November 2025
Revolutionizing Bioanalysis for AntibodysiRNA Conjugates: Evolving ELISA Platforms & siRNA Quantitation Strategies
11:30 am
  • Explaining the lack of a simple method to quantify antibody-siRNA conjugates to set specifications in GMP testing
  • Leveraging Nanoluc technology to evolve ELISA methodology for antibody-siRNA conjugate quantification in manufacturing batches
  • Exploring advantages of quantification method and plans for future development
Oluwatoyin Areo - 16th World ADC San Diego